Urocortin III is expressed in pancreatic beta-cells and stimulates insulin and glucagon secretion - PubMed (original) (raw)
. 2003 Jul;144(7):3216-24.
doi: 10.1210/en.2002-0087.
Affiliations
- PMID: 12810578
- DOI: 10.1210/en.2002-0087
Urocortin III is expressed in pancreatic beta-cells and stimulates insulin and glucagon secretion
Chien Li et al. Endocrinology. 2003 Jul.
Abstract
Urocortin (Ucn) III, or stresscopin, is a high affinity ligand for the type 2 corticotropin-releasing factor (CRFR2) receptor recently identified in rodents and human. Ucn III was initially identified as a neuropeptide expressed in discrete areas in the brain. In the present study, we demonstrate that Ucn III is expressed in pancreatic beta-cells and in a mouse beta-cell line, MIN6. Ucn III secretion from the cells was measured using a highly specific RIA, and we found that high potassium, forskolin, or high glucose can stimulate Ucn III secretion from these cells. In vivo studies showed that rats receiving an iv Ucn III injection had a significant elevation of plasma glucagon followed by plasma glucose levels compared with rats receiving vehicle. Ucn III injections also result in an increase in plasma insulin levels. The observed effects of Ucn III were blocked by pretreatment with a CRFR2 antagonist, astressin(2)-B. Furthermore, Ucn III stimulated glucagon and insulin release from isolated rat islets, and astressin(2)-B abolished the effects of Ucn III, in keeping with a CRFR2-mediated mechanism. Taken together, the present studies suggest pancreatic Ucn III acting through CRFR2 is involved in the local regulation of glucagon and insulin secretion.
Similar articles
- Urocortin 3 regulates glucose-stimulated insulin secretion and energy homeostasis.
Li C, Chen P, Vaughan J, Lee KF, Vale W. Li C, et al. Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4206-11. doi: 10.1073/pnas.0611641104. Epub 2007 Feb 27. Proc Natl Acad Sci U S A. 2007. PMID: 17360501 Free PMC article. - Stimulation of rat pancreatic exocrine secretion by urocortin and corticotropin releasing factor.
Guzman EA, Zhang W, Lin TR, Mulholland MW. Guzman EA, et al. Peptides. 2003 May;24(5):727-34. doi: 10.1016/s0196-9781(03)00125-6. Peptides. 2003. PMID: 12895659 - Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.
Brar BK, Jonassen AK, Egorina EM, Chen A, Negro A, Perrin MH, Mjøs OD, Latchman DS, Lee KF, Vale W. Brar BK, et al. Endocrinology. 2004 Jan;145(1):24-35; discussion 21-3. doi: 10.1210/en.2003-0689. Epub 2003 Sep 11. Endocrinology. 2004. PMID: 12970163 - The neurobiology of urocortin.
Skelton KH, Owens MJ, Nemeroff CB. Skelton KH, et al. Regul Pept. 2000 Sep 25;93(1-3):85-92. doi: 10.1016/s0167-0115(00)00180-4. Regul Pept. 2000. PMID: 11033056 Review. - Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
Hashimoto K, Nishiyama M, Tanaka Y, Noguchi T, Asaba K, Hossein PN, Nishioka T, Makino S. Hashimoto K, et al. Peptides. 2004 Oct;25(10):1711-21. doi: 10.1016/j.peptides.2004.05.024. Peptides. 2004. PMID: 15476938 Review.
Cited by
- Stereological analyses of the whole human pancreas.
Poudel A, Fowler JL, Zielinski MC, Kilimnik G, Hara M. Poudel A, et al. Sci Rep. 2016 Sep 23;6:34049. doi: 10.1038/srep34049. Sci Rep. 2016. PMID: 27658965 Free PMC article. - Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion.
van der Meulen T, Donaldson CJ, Cáceres E, Hunter AE, Cowing-Zitron C, Pound LD, Adams MW, Zembrzycki A, Grove KL, Huising MO. van der Meulen T, et al. Nat Med. 2015 Jul;21(7):769-76. doi: 10.1038/nm.3872. Epub 2015 Jun 15. Nat Med. 2015. PMID: 26076035 Free PMC article. - Reversal of β cell de-differentiation by a small molecule inhibitor of the TGFβ pathway.
Blum B, Roose AN, Barrandon O, Maehr R, Arvanites AC, Davidow LS, Davis JC, Peterson QP, Rubin LL, Melton DA. Blum B, et al. Elife. 2014 Sep 16;3:e02809. doi: 10.7554/eLife.02809. Elife. 2014. PMID: 25233132 Free PMC article. - Urocortin 3 activates AMPK and AKT pathways and enhances glucose disposal in rat skeletal muscle.
Roustit MM, Vaughan JM, Jamieson PM, Cleasby ME. Roustit MM, et al. J Endocrinol. 2014 Nov;223(2):143-54. doi: 10.1530/JOE-14-0181. Epub 2014 Aug 13. J Endocrinol. 2014. PMID: 25122003 Free PMC article. - Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs.
Fekete EM, Zorrilla EP. Fekete EM, et al. Front Neuroendocrinol. 2007 Apr;28(1):1-27. doi: 10.1016/j.yfrne.2006.09.002. Epub 2006 Nov 2. Front Neuroendocrinol. 2007. PMID: 17083971 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous